Contralateral Claims Study of Clareon Vivity Pro

Conditions: Aphakia, Presbyopia

Sex: All

Ages: 22 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 231

Sponsor: Alcon Research

Location: iVision Clinic Campsie New South Wales

Summary

The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.

Eligibility Criteria

Key Inclusion Criteria: * Cataracts in both eyes. * Preoperative corneal astigmatism of less than 1.00 diopter (D) in each eye. * Potential postoperative best corrected visual acuity (BCDVA) of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator. * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Desires monovision correction. * Predicted post-operative residual astigmatism of more than 1D in either eye. * Any ocular or systemic co-morbidity that, in the investigator's medical opinion, may confound the results of this study, prohibit the completion of the study assessments, or increase the risk for the subject. * Other protocol-defined exclusion criteria may apply.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07484191). StuddyBuddy aggregates publicly available trial information.